Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Abiomed gains some Wall Street favor after publishing positive findings from a study comparing its Impella 2.5 heart pump in a head-to-head against intra aortic balloon pump support.
With Curt Hartman entering his 7th month as interim CEO, some analysts are hoping medical device company Stryker will use its upcoming analyst meeting this week to name a permanent top man.
Analysts speculate that St. Jude Medical’s wide-scale restructuring and hundreds of layoffs may be related to the impending burden of the 2.3% medical device tax slated to take effect January 1.